Utilizziamo i cookie per offrirti una migliore esperienza di navigazione, analizzare il traffico e personalizzare i contenuti. Scopri di più su come utilizziamo i cookie e sulla nostra politica sulla privacy e termini di utilizzo. Se continui a utilizzare questo siti, acconsenti all’utilizzo dei cookie.

Accetto

Filtro di ricerca

Comunicati stampa

Scopri tutto su i nostri comunicati stampa recenti, resta aggiornato sulle ultime notizie e informati sui prossimi eventi a cui Curium parteciperà.

25th Gennaio 2022

Curium to become major player in the supply on non carrier added Lu-177

15th Dicembre 2021

Curium is pleased to announce that Sakir Mutevelic MD, MSc has joined as global Chief Medical Officer

27th Ottobre 2021

Curium Initiates ECLIPSE, a Phase 3 Clinical Trial For Its Investigational Lu 177 PSMA I&T

24th Agosto 2021

Curium Announces Submission of an Investigational New Drug (IND) Application for Cu-64 PSMA I&T

1st Giugno 2021

Curium Acquires Austrian Radiopharmaceuticals Company IASON

5th Maggio 2021

RadioMedix & Curium Announce Detectnet™ (copper Cu 64 dotatate injection) Inclusion on NCCN Guidelines®

4th Maggio 2021

Curium Announces Filing of a Generic Version of DaTscan™ (Ioflupane I 123 Injection) in the U.S.

28th Aprile 2021

Curium to Expand Noblesville Facility’s Workforce

23rd Marzo 2021

RadioMedix & Curium Announce Simplified Coding for Detectnet™ (copper Cu 64 dotatate injection)

2nd Marzo 2021

Eckert & Ziegler’s GalliaPharm® distributed by Curium in France

26th Gennaio 2021

RadioMedix & Curium Announce Permanent HCPCS Code for Detectnet™ (copper Cu 64 dotatate injection)

9th Dicembre 2020

RadioMedix & Curium Announce CMS Transitional Pass-Through Status for Detectnet™ (copper Cu 64 dotatate injection)

8th Settembre 2020

RadioMedix and Curium Announce FDA Approval of Detectnet (copper Cu 64 dotatate injection) in the U.S.

9th Giugno 2020

Curium Announces Drug Master File and Active Substance Master File for Germanium-68 in the U.S. and Europe

24th Marzo 2020

Curium Announces Approval of Pulmotech^TM MAA (kit for the preparation of technetium Tc 99m albumin aggregated injection) by the U.S. Food and Drug Administration

12th Marzo 2020

RadioMedix and Curium Announce copper Cu 64 dotatate injection Was Granted Priority Review by the U.S. FDA

3rd Marzo 2020

Curium Acquires Zevacor Molecular Strengthening Its PET Portfolio

7th Gennaio 2020

RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application

2nd Dicembre 2019

Curium Acquires Finnish Radiopharmaceuticals Company MAP Medical Technologies Oy

4th Settembre 2019

Filtrar per

Comunicati stampa

Curium to become major player in the supply on non carrier added Lu-177

Curium is pleased to announce that Sakir Mutevelic MD, MSc has joined as global Chief Medical Officer

Curium Initiates ECLIPSE, a Phase 3 Clinical Trial For Its Investigational Lu 177 PSMA I&T

Curium Announces Submission of an Investigational New Drug (IND) Application for Cu-64 PSMA I&T

Curium Acquires Austrian Radiopharmaceuticals Company IASON

RadioMedix & Curium Announce Detectnet™ (copper Cu 64 dotatate injection) Inclusion on NCCN Guidelines®

Curium Announces Filing of a Generic Version of DaTscan™ (Ioflupane I 123 Injection) in the U.S.

Curium to Expand Noblesville Facility’s Workforce

RadioMedix & Curium Announce Simplified Coding for Detectnet™ (copper Cu 64 dotatate injection)

Eckert & Ziegler’s GalliaPharm® distributed by Curium in France

RadioMedix & Curium Announce Permanent HCPCS Code for Detectnet™ (copper Cu 64 dotatate injection)

RadioMedix & Curium Announce CMS Transitional Pass-Through Status for Detectnet™ (copper Cu 64 dotatate injection)

RadioMedix and Curium Announce FDA Approval of Detectnet (copper Cu 64 dotatate injection) in the U.S.

Curium Announces Drug Master File and Active Substance Master File for Germanium-68 in the U.S. and Europe

Curium Announces Approval of Pulmotech^TM MAA (kit for the preparation of technetium Tc 99m albumin aggregated injection) by the U.S. Food and Drug Administration

RadioMedix and Curium Announce copper Cu 64 dotatate injection Was Granted Priority Review by the U.S. FDA

Curium Acquires Zevacor Molecular Strengthening Its PET Portfolio

RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application

Curium Acquires Finnish Radiopharmaceuticals Company MAP Medical Technologies Oy

Curium Announces Revised Pricing for Technescan MAG3^TM (kit for the preparation of technetium Tc 99m mertiatide)

Filtrar per

Comunicati stampa

Curium to become major player in the supply on non carrier added Lu-177

Curium is pleased to announce that Sakir Mutevelic MD, MSc has joined as global Chief Medical Officer

Curium Initiates ECLIPSE, a Phase 3 Clinical Trial For Its Investigational Lu 177 PSMA I&T

Curium Announces Submission of an Investigational New Drug (IND) Application for Cu-64 PSMA I&T

Curium Acquires Austrian Radiopharmaceuticals Company IASON

RadioMedix & Curium Announce Detectnet™ (copper Cu 64 dotatate injection) Inclusion on NCCN Guidelines®

Curium Announces Filing of a Generic Version of DaTscan™ (Ioflupane I 123 Injection) in the U.S.

Curium to Expand Noblesville Facility’s Workforce

RadioMedix & Curium Announce Simplified Coding for Detectnet™ (copper Cu 64 dotatate injection)

Eckert & Ziegler’s GalliaPharm® distributed by Curium in France

RadioMedix & Curium Announce Permanent HCPCS Code for Detectnet™ (copper Cu 64 dotatate injection)

RadioMedix & Curium Announce CMS Transitional Pass-Through Status for Detectnet™ (copper Cu 64 dotatate injection)

RadioMedix and Curium Announce FDA Approval of Detectnet (copper Cu 64 dotatate injection) in the U.S.

Curium Announces Drug Master File and Active Substance Master File for Germanium-68 in the U.S. and Europe

Curium Announces Approval of PulmotechTM MAA (kit for the preparation of technetium Tc 99m albumin aggregated injection) by the U.S. Food and Drug Administration

RadioMedix and Curium Announce copper Cu 64 dotatate injection Was Granted Priority Review by the U.S. FDA

Curium Acquires Zevacor Molecular Strengthening Its PET Portfolio

RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application

Curium Acquires Finnish Radiopharmaceuticals Company MAP Medical Technologies Oy

Curium Announces Revised Pricing for Technescan MAG3TM (kit for the preparation of technetium Tc 99m mertiatide)

Curium Announces Approval of Pulmotech^TM MAA (kit for the preparation of technetium Tc 99m albumin aggregated injection) by the U.S. Food and Drug Administration

Curium Announces Revised Pricing for Technescan MAG3^TM (kit for the preparation of technetium Tc 99m mertiatide)